2D and 3D cartilage models for drug testing and high throughput
screening – the impact of PORCN inhibition on cartilage
development.

Skip to top bar Skip to header Skip to content Skip to footer

Publications Detailed Information on Publication Record

Detailed Information on Publication Record

a 2022

2D and 3D cartilage models for drug testing and high throughput screening – the impact of PORCN inhibition on cartilage development.

KILLINGER, Michael, Tereza SZOTKOWSKÁ, Marcela BUCHTOVÁ and Karel KLEPÁRNÍK

Basic information

Original name

2D and 3D cartilage models for drug testing and high throughput screening – the impact of PORCN inhibition on cartilage development.

Authors

KILLINGER, Michael, Tereza SZOTKOWSKÁ, Marcela BUCHTOVÁ and Karel KLEPÁRNÍK

Edition

NanoBioTech-Montreux Conference, Montreux, Switzerland, 2022

Other information

Type of outcome

Konferenční abstrakt

Confidentiality degree

není předmětem státního či obchodního tajemství

Změněno: 19/5/2023 13:10, Mgr. Michael Killinger, Ph.D., DiS.

KILLINGER, Michael, Tereza SZOTKOWSKÁ, Marcela BUCHTOVÁ and Karel KLEPÁRNÍK. 2D and 3D cartilage models for drug testing and high throughput screening – the impact of PORCN inhibition on cartilage development. In NanoBioTech-Montreux Conference, Montreux, Switzerland. 2022.

@proceedings{2283942,
   author = {Killinger, Michael and Szotkowská, Tereza and Buchtová, Marcela and Klepárník, Karel},
   booktitle = {NanoBioTech-Montreux Conference, Montreux, Switzerland},
   title = {2D and 3D cartilage models for drug testing and high throughput screening – the impact of PORCN inhibition on cartilage development.},
   year = {2022}
}

TY  - CONF
ID  - 2283942
AU  - Killinger, Michael - Szotkowská, Tereza - Buchtová, Marcela - Klepárník, Karel
PY  - 2022
TI  - 2D and 3D cartilage models for drug testing and high throughput screening – the impact of PORCN inhibition on cartilage development.
ER  -

KILLINGER, Michael, Tereza SZOTKOWSKÁ, Marcela BUCHTOVÁ and Karel KLEPÁRNÍK. 2D and 3D cartilage models for drug testing and high throughput screening – the impact of PORCN inhibition on cartilage development. In \textit{NanoBioTech-Montreux Conference, Montreux, Switzerland}. 2022.